Topical non-steroidal anti-inflammatory drugs vs musculoskeletal pain: the focus of the topical patch Menovazan PRO

February 29, 2024
413
УДК:  616.74+616.72
Resume

Current World Health Organization guidelines and international, American, European and Chinese guidelines recommend the use of topical non-steroidal anti-inflammatory drugs as first-line treatment for musculoskeletal pain due to their comparable efficacy to oral non-steroidal anti-inflammatory drugs and better safety than the latter. The topical patch Menovazan PRO, which contains menthol, meloxicam, procaine and benzocaine, has analgesic, anti-inflammatory and cooling effects. Menovazan PRO is recommended for the mild/moderate musculoskeletal pain of traumatic, inflammatory and dystrophic genesis; it can be used in patients with comorbid gastrointestinal and cardiovascular pathology.

References

  • 1. McMahon S.B., Dargan P., Lanas A. et al. (2021) The burden of musculoskeletal pain and the role of topical non-steroidal anti-inflammatory drugs (NSAIDs) in its treatment. Ten underpinning statements from a global pain faculty. Curr. Med. Res. Opin., 37(2): 287–292.
  • 2. http://www.who.int/news-room/fact-sheets/detail/musculoskeletal-conditions.
  • 3. Anekar A.A., Hendrix J.M., Cascella M. (2024) WHO Analgesic Ladder. Treasure Island.
  • 4. Qaseem A., McLean R.M., O’Gurek D. et al. (2020) Nonpharmacologic and Pharmacologic Management of Acute Pain From Non-Low Back, Musculoskeletal Injuries in Adults: A Clinical Guideline From the American College of Physicians and American Academy of Family Physicians. Ann. Intern. Med., 173(9): 739–748.
  • 5. Shi C., Ye Z., Shao Z. et al. (2023) Multidisciplinary Guidelines for the Rational Use of Topical Non-Steroidal Anti-Inflammatory Drugs for Musculoskeletal Pain. J. Clin. Med.,12: 1544.
  • 6. Kloppenburg M., Kroon F.P., Blanco F. et al. (2019) 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann. Rheum. Dis., 78(1): 16–24.
  • 7. Hunt R., Lazebnik L., Marakhouski Y. et al. (2018) International Consensus on Guiding Recommendations for Management of Patients with Nonsteroidal Antiinflammatory Drugs Induced Gastropathy-ICON-G. Euroasian J. Hepatogastroenterol., 8(2): 148–160.
  • 8. Mohammadi-Samani S., Yousefi G., Mohammadi F. et al. (2014) Meloxicam transdermal delivery: effect of eutectic point on the rate and extent of skin permeation. Iran J. Basic Med. Sci., 17(2): 112–118.
  • 9. Leppert W., Malec-Milewska M., Zajaczkowska R. et al. (2018) Transdermal and Topical Drug Administration in the Treatment of Pain. Molecules, 23(3): 681.
  • 10. compendium.com.ua/med/563153/867413.
  • 11. Chen J., Gao Y. (2016) Strategies for meloxicam delivery to and across the skin: a review. Drug Deliv., 23(8): 3146–3156. doi: 10.3109/10717544.2016.1157839.
  • 12. Drakalska Sersemova Е. (2022) Evaluation of topical preparations of meloxicam — a review. Knowledge, 4: 749–754.
  • 13. Yuan Y., Chen X.Y., Li S. et al. (2009) Pharmacokinetic studies of meloxicam following oral and transdermal administration in Beagle dogs. Acta Pharmacol. Sin., 30(7): 1060–1064.
  • 14. Jyothi V., Veerabomma H., Tryphena K. et al. (2023) Acute and sub-acute dermal toxicity of meloxicam emulgel: Analysis of biochemical, hematological, histopathological and immunohistochemical expression. Biochem. Biophys. Res. Commun., 660: 88–95. doi: 10.1016/j.bbrc.2023.04.001.
  • 15. Zhang Z.J., Osmałek T., Michniak-Kohn B. (2020) Deformable Liposomal Hydrogel for Dermal and Transdermal Delivery of Meloxicam. Int. J. Nanomedicine, 15: 9319–9335. doi: 10.2147/IJN.S274954.
  • 16. Li Z., Zhang H., Wang Y. et al. (2022) The distinctive role of menthol in pain and analgesia: Mechanisms, practices, and advances. Front Mol. Neurosci., 15: 1006908.
  • 17. Wang G., Hurr C. (2023) Effects of cutaneous administration of an over-the-counter menthol cream during temperate-water immersion for exercise-induced hyperthermia in men. Front. Physiol., 14: 1161240. doi: 10.3389/fphys.2023.1161240.
  • 18. Whalen A., Farrell K., Roberts S. et al. (2019) Topical Analgesic Improved or Maintained Ballistic Hip Flexion Range of Motion with Treated and Untreated Legs. J. Sports Sci. Med., 18(3): 552–558.
  • 19. Üstündağ Okur N., Çağlar E.Ş., Arpa M. et al. (2017) Preparation and evaluation of novel microemulsion-based hydrogels for dermal delivery of benzocaine. Pharm. Dev. Technol., 22(4): 500–510. doi: 10.3109/10837450.2015.1131716.
  • 20. Eslamian L., Borzabadi-Farahani A., Edini H. (2013) The analgesic effect of benzocaine mucoadhesive patches on orthodontic pain caused by elastomeric separators, a preliminary study. Acta Odontol. Scand., 71(5): 1168–1173.
  • 21. Mei F., Li J., Zhang L. et al. (2022) Preference of Orthopedic Practitioners Toward the Use of Topical Medicine for Musculoskeletal Pain Management in China: A National Survey. Orthop. Surg., 14(10): 2470–2479. doi: 10.1111/os.13446.
  • 22. Takeda O., Chiba D., Ishibashi Y. et al. (2017) Patient-Physician Differences in Desired Characteristics of NSAID Plasters: An Online Survey. Pain Res. Manag., 2017: 5787854.